CLINICAL_TRIALS
trial_result
· 2023-08-29
Clinical Trial Update: Adrabetadex to Treat Niemann-Pick Type C1 (NPC1) Disease [Phase 2, Phase 3]
Summary
Clinical trial update for adrabetadex in Niemann-Pick disease type C1 (NPC1) has terminated after Phase 2/3; results posted were in 2023.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Mandos LLC | Conditions: Niemann-Pick Disease, Type C | Phase 2, Phase 3 | Status: TERMINATED | Results posted: 2023-08-29